Medical Plastics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Global Medical Plastics Market Report Segments the Industry by Type (Traditional Plastics and Engineering Plastics), Process (Injection Molding, Extrusion, Blow Molding, and More), Application (Disposables, Sterilization Trays, Surgical Instruments, and More), and Geography (Asia-Pacific, North America, Europe, South America, and Middle-East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Medical Plastics Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Medical Plastics Market with other markets in Chemicals & Materials Industry

Medical Plastics Market Analysis by Mordor Intelligence

The Medical Plastics Market size is estimated at USD 27.46 billion in 2025, and is expected to reach USD 36 billion by 2030, at a CAGR of 5.56% during the forecast period (2025-2030). Softer outpatient models, rapid device miniaturization, and government-backed manufacturing incentives are raising demand for lightweight, sterile polymers across disposables, drug-delivery systems, and patient-specific implants. Polypropylene remains the workhorse thanks to its balanced cost-performance profile, while polyether-ether-ketone (PEEK) is scaling quickly in high-value implants because of its bone-like mechanical behavior. Injection molding keeps its lead for mass-volume precision parts, yet additive manufacturing is reshaping personalized care workflows. Asia-Pacific combines the largest installed capacity with the fastest consumption growth, driven by policy support in China and India and an expanding regional export hub for class II and class III devices.

Key Report Takeaways

  • By polymer type, polypropylene led with 26.19% revenue share in 2024, while PEEK is projected to expand at a 5.91% CAGR through 2030. 
  • By process, injection molding accounted for 42.84% of the medical plastics market share in 2024; 3-D printing records the strongest 5.87% CAGR to 2030. 
  • By application, disposables captured 37.19% of the medical plastics market size in 2024, whereas the other applications bucket (drug-delivery devices and pharmaceutical packaging) advances at a 6.12% CAGR through 2030. 
  • By region, Asia-Pacific commanded 41.56% of the medical plastics market in 2024 and is growing at 6.04% CAGR to 2030.

Segment Analysis

By Type: Polypropylene Reigns, PEEK Gains Momentum

Polypropylene accounted for 26.19% of the medical plastics market share in 2024, anchored in syringes, IV bags, and catheter hubs that require chemical resistance and steam-autoclave tolerance. The material’s density of 0.9 g/cm³ supports lighter shipping loads, reinforcing its cost advantage. Polymer scientists are exploring catalytic depolymerization to transform spent PP masks into ECG electrodes, an initiative that could lower landfill volumes while adding value. 

PEEK is projected to log a 5.91% CAGR to 2030, outpacing all other engineering resins. Demand stems from spinal cages, dental abutments, and cranial plates printed to patient CT data. The medical plastics market size for PEEK-based implants is poised to expand as material suppliers commercialize high-flow grades that shorten print cycles without sacrificing crystallinity. Radiolucency and modulus matching make PEEK attractive versus titanium, and emerging recycling programs for machining scraps enhance its sustainability profile.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Process: Injection Molding Holds Scale While 3-D Printing Disrupts

Injection molding represented 42.84% of the medical plastics market in 2024 by virtue of cycle-time efficiency and micron-level repeatability. Gas-assisted and thin-wall variants shave resin usage in connector bodies and ventilator housings. Computer vision and AI-driven cavity balancing further reduce scrap rates, a key cost driver in low-margin disposables. The medical plastics market size tied to injection molding thus remains resilient.

3D Printing captures less total volume today, yet is growing 5.87% annually, the fastest among processes. Stereolithography dominates dental aligners, where one million parts are printed daily. Powder-bed fusion of PEEK and bioresorbables is scaling into trauma plates and soft-tissue scaffolds. Hospitals adopting in-house printers shorten lead times from weeks to days, a value proposition that will push the medical plastics market toward mass customization.

By Application: Disposables Lead, Connected Drug-Delivery Advances

Disposables retained a 37.19% share in 2024 on the back of infection-control mandates and rising outpatient procedures. Syringe-in-barrel innovations, closed-loop catheter systems, and low-dead-volume connectors improve dose accuracy while reducing pathogen exposure. Yet these single-use volumes elevate waste-management scrutiny, compelling buyers to audit resin provenance and life-cycle impacts. Even so, the medical plastics market continues to rely on disposables for frontline infection control.

The other-applications segment, which clusters drug-delivery devices and pharmaceutical packaging, will expand 6.12% per year through 2030. Digital dose-tracking pumps require optically clear, solvent-resistant housings that safeguard circuitry; transparent copolymer polycarbonates are emerging candidates. Demand for tamper-evident, high-barrier vials that preserve next-generation biologics adds further traction. These developments sustain growth momentum within the medical plastics market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

Asia-Pacific captured 41.56% of the medical plastics market in 2024 and is forecast to widen its lead at a 6.04% CAGR. China’s export of medical devices to ASEAN hit USD 4.4 billion in 2023, a testament to regionalized supply chains. Japan contributes precision molding know-how that supports high-end diagnostic components. These dynamics position Asia as both a manufacturing hub and a consumption epicenter for the medical plastics market.

North America remains the innovation nucleus, especially for 3-D-printed implants and connected therapeutics. Stringent FDA class-II and class-III standards drive the adoption of resins with well-documented biocompatibility, and hospital construction trends favor modular outpatient clinics needing lightweight, recyclable fixtures.

Europe approaches the market through a sustainability prism. The Single-Use Plastics Directive pressures device makers to switch from styrenics to lower-impact copolymers or biodegradable alternatives. In Germany and the Netherlands, pilot recycling hubs are testing closed-loop programs for PET tracer vials and PVC masks. Academic-industry consortia funded under Horizon Europe add to the research pipeline that targets circular medical plastics market solutions. Meanwhile, South America and the Middle-East and Africa expand baseline healthcare infrastructure, prioritizing affordable disposables and basic diagnostic kits as entry points into the medical plastics market.

Medical Plastics Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The medical plastics market is highly fragmented, and hundreds of regional compounders serve niche sterilizable grades. Mid-tier specialists pursue market share through targeted certifications. Teknor Apex broadened its thermoplastic elastomer (TPE) portfolio for biopharmaceutical tubing in November 2024, offering low-extractable grades that withstand aggressive cleaning agents. Digital twins and AI-driven process controls further differentiate suppliers able to minimize scrap and speed validation. Collectively, these moves intensify competition yet also accelerate innovation within the medical plastics market.

Medical Plastics Industry Leaders

  1. Celanese Corporation

  2. Dow

  3. DuPont

  4. SABIC

  5. Solvay

  6. *Disclaimer: Major Players sorted in no particular order
Medical Plastics Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • November 2024: Teknor Apex expanded its medical-grade TPE line for biopharmaceutical tubing applications, targeting low-extractables performance.
  • May 2024: Covestro has opened a new solvent-free polycarbonate copolymer plant in Antwerp, targeting applications in the electronics and healthcare sectors. The facility underscores the company’s commitment to sustainable, high-performance materials.

Table of Contents for Medical Plastics Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Shift Toward Home-Based Care Requiring Lightweight Single-Use Devices
    • 4.2.2 Miniaturization of Catheters and Wearables Elevating Demand for High-Purity Polycarbonate in Cardiovascular Applications
    • 4.2.3 Government Incentives for Domestic Medical-Device Manufacturing in Asia
    • 4.2.4 Rapid Adoption of 3-D Printed Patient-Specific Implants Accelerating PEEK Utilization Globally
    • 4.2.5 Growth of Connected Drug-Delivery Pumps Driving Use of Transparent, Chemically-Resistant Polymers
  • 4.3 Market Restraints
    • 4.3.1 Environmental Concerns Regarding Medical Plastics
    • 4.3.2 Limited Recycling Infrastructure for Medical-Grade Plastics Heightening Disposal Expenses
    • 4.3.3 Increasing Competition from Alternative Materials
  • 4.4 Value Chain Analysis
  • 4.5 Porter's Five Forces
    • 4.5.1 Bargaining Power of Suppliers
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Threat of New Entrants
    • 4.5.4 Threat of Substitutes
    • 4.5.5 Degree of Competition

5. Market Size and Growth Forecasts (Value)

  • 5.1 By Type
    • 5.1.1 Traditional Plastics
    • 5.1.1.1 Polyethylene (PE)
    • 5.1.1.2 Polypropylene (PP)
    • 5.1.1.3 Polystyrene (PS)
    • 5.1.1.4 Polyvinyl Chloride (PVC)
    • 5.1.2 Engineering Plastics
    • 5.1.2.1 Acrylonitrile-Butadiene-Styrene (ABS)
    • 5.1.2.2 Polycarbonate (PC)
    • 5.1.2.3 Polymethyl-Methacrylate (PMMA)
    • 5.1.2.4 Polyether-Ether-Ketone (PEEK)
    • 5.1.2.5 Polyoxymethylene (POM)
    • 5.1.2.6 Polyphenylene Oxide (PPO)
    • 5.1.2.7 Other Engineering Plastics
  • 5.2 By Process
    • 5.2.1 Injection Molding
    • 5.2.2 Extrusion
    • 5.2.3 Blow Molding
    • 5.2.4 3-D Printing / Additive Manufacturing
    • 5.2.5 Others (Compression, Thermoforming)
  • 5.3 By Application
    • 5.3.1 Disposables
    • 5.3.2 Sterilization Trays
    • 5.3.3 Surgical Instruments
    • 5.3.4 Diagnostic Instruments
    • 5.3.5 Anasthetics and Imagining Equipments
    • 5.3.6 Others (Drug-Delivery Devices, Pharmaceutical and Device Packaging)
  • 5.4 By Geography
    • 5.4.1 Asia-Pacific
    • 5.4.1.1 China
    • 5.4.1.2 India
    • 5.4.1.3 Japan
    • 5.4.1.4 South Korea
    • 5.4.1.5 Rest of Asia-Pacifc
    • 5.4.2 North America
    • 5.4.2.1 United States
    • 5.4.2.2 Canada
    • 5.4.2.3 Mexico
    • 5.4.3 Europe
    • 5.4.3.1 Germany
    • 5.4.3.2 United Kingdom
    • 5.4.3.3 France
    • 5.4.3.4 Italy
    • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle-East and Africa
    • 5.4.5.1 Saudi Arabia
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle-East and Africa

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share(%)/Ranking Analysis
  • 6.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)}
    • 6.4.1 BASF
    • 6.4.2 Celanese Corporation
    • 6.4.3 Covestro
    • 6.4.4 Dow
    • 6.4.5 dsm-firmenich
    • 6.4.6 DuPont
    • 6.4.7 Eastman Chemical Company
    • 6.4.8 Ensinger
    • 6.4.9 Evonik Industries AG
    • 6.4.10 Mitsubishi Chemical Group Corporation
    • 6.4.11 Nolato AB
    • 6.4.12 RAUMEDIC AG
    • 6.4.13 Röchling SE & Co. KG
    • 6.4.14 RTP Company
    • 6.4.15 SABIC
    • 6.4.16 Saint-Gobain
    • 6.4.17 Solvay
    • 6.4.18 Teknor Apex
    • 6.4.19 Westlake Plastics

7. Market Opportunities and Future Outlook

  • 7.1 White-Space and Unmet-Need Assessment
  • 7.2 Increasing Investment in 3-D Printing and Imaging Technologies
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Medical Plastics Market Report Scope

The Medical Plastics market report includes:

By Type Traditional Plastics Polyethylene (PE)
Polypropylene (PP)
Polystyrene (PS)
Polyvinyl Chloride (PVC)
Engineering Plastics Acrylonitrile-Butadiene-Styrene (ABS)
Polycarbonate (PC)
Polymethyl-Methacrylate (PMMA)
Polyether-Ether-Ketone (PEEK)
Polyoxymethylene (POM)
Polyphenylene Oxide (PPO)
Other Engineering Plastics
By Process Injection Molding
Extrusion
Blow Molding
3-D Printing / Additive Manufacturing
Others (Compression, Thermoforming)
By Application Disposables
Sterilization Trays
Surgical Instruments
Diagnostic Instruments
Anasthetics and Imagining Equipments
Others (Drug-Delivery Devices, Pharmaceutical and Device Packaging)
By Geography Asia-Pacific China
India
Japan
South Korea
Rest of Asia-Pacifc
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Rest of Europe
South America Brazil
Argentina
Rest of South America
Middle-East and Africa Saudi Arabia
South Africa
Rest of Middle-East and Africa
By Type
Traditional Plastics Polyethylene (PE)
Polypropylene (PP)
Polystyrene (PS)
Polyvinyl Chloride (PVC)
Engineering Plastics Acrylonitrile-Butadiene-Styrene (ABS)
Polycarbonate (PC)
Polymethyl-Methacrylate (PMMA)
Polyether-Ether-Ketone (PEEK)
Polyoxymethylene (POM)
Polyphenylene Oxide (PPO)
Other Engineering Plastics
By Process
Injection Molding
Extrusion
Blow Molding
3-D Printing / Additive Manufacturing
Others (Compression, Thermoforming)
By Application
Disposables
Sterilization Trays
Surgical Instruments
Diagnostic Instruments
Anasthetics and Imagining Equipments
Others (Drug-Delivery Devices, Pharmaceutical and Device Packaging)
By Geography
Asia-Pacific China
India
Japan
South Korea
Rest of Asia-Pacifc
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Rest of Europe
South America Brazil
Argentina
Rest of South America
Middle-East and Africa Saudi Arabia
South Africa
Rest of Middle-East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the size of the global medical plastics market in 2025?

The market is valued at USD 27.46 billion in 2025.

How fast will the medical plastics market grow through 2030?

It is projected to expand at a 5.56% CAGR, reaching USD 36 billion by 2030.

Which polymer holds the largest share of the market?

Polypropylene leads with 26.19% share because of its cost-effectiveness and versatility in single-use devices.

Which application category represents the biggest revenue contributor?

Disposables command 37.19% of global revenue, driven by strict infection-control protocols.

Which region dominates medical plastics demand today?

Asia-Pacific accounts for 41.56% of global consumption and also records the fastest 6.04% CAGR to 2030.

Page last updated on: July 1, 2025

Medical Plastics Market Report Snapshots